# George King Bio-Medical, Inc.

- Location (FDA's records): Overland Park, KS
- FDA decisions: 5 (1995–2017): 5 510(k) clearances
- Product codes: GGN (3), GJT (1), GGC (1)
- Predicates its devices cite: 1 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Precision Biologicals, Inc.: 1 (https://510kreport.com/company/precision-biologicals)

## Recent decisions
- K161316: George King Coumadin Plasma (Feb 23, 2017)
- K945855: A-Fact, Abnormal Factor Assay Control (Oct 24, 1995)
- K945854: B-Fact, Borderline Factor Assay Control (Oct 24, 1995)
- K945857: Protein C Deficient Plasma (Oct 20, 1995)
- K945856: Positive Lupus Anticoagulant Plasma (Oct 5, 1995)

Source page: https://510kreport.com/company/george-king-bio-medical